Cagent Vascular
Wayne
About Cagent Vascular
Cagent Vascular develops a serration technology for improving the treatment of cardiovascular disease. Its commercialized angioplasty balloon with serration technology treats blocked arteries in the leg or peripheral artery disease and chronic limb-threatening ischemia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $66.9M
- Last round: Series Unknown (Feb 2025)
- Website: cagentvascular.com
- Phone: 610-688-2006
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cagent-vascular-34318 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.